RPL10 — Ribosomal Protein L10

RPL10 — Ribosomal Protein L10

<div class="infobox infobox-gene">
| Gene | |
|---|---|
| Symbol | RPL10 |
| Full Name | Ribosomal Protein L10 |
| Chromosome | Xq28 |
| NCBI Gene ID | 6135 |
| UniProt ID | [P83731](https://www.uniprot.org/uniprotkb/P83731) |
| Ensembl | [ENSG00000149499](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000149499) |
| Protein Class | Ribosomal protein, large subunit |
| Alternative Names | L10, QM, DXS983 |
</div>

Overview

RPL10 (Ribosomal Protein L10) encodes a component of the large (60S) ribosomal subunit essential for protein synthesis in all cells, including [neurons](/cell-types/neurons). Originally identified as a tumor suppressor (QM protein), RPL10 has gained attention for its role in neurodegenerative diseases through connections to translation regulation, ribosomal dysfunction, and protein homeostasis failures that are central to [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) [1](https://pubmed.ncbi.nlm.nih.gov/25776775/).

Mutations in RPL10 and related ribosomal proteins cause X-linked intellectual disability and have been implicated in autism spectrum disorders, highlighting the importance of proper ribosomal function in neurodevelopment [2](https://pubmed.ncbi.nlm.nih.gov/25494167/). This page provides a comprehensive overview of RPL10's molecular function, disease associations, and therapeutic implications.

RPL10 — Ribosomal Protein L10

<div class="infobox infobox-gene">
| Gene | |
|---|---|
| Symbol | RPL10 |
| Full Name | Ribosomal Protein L10 |
| Chromosome | Xq28 |
| NCBI Gene ID | 6135 |
| UniProt ID | [P83731](https://www.uniprot.org/uniprotkb/P83731) |
| Ensembl | [ENSG00000149499](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000149499) |
| Protein Class | Ribosomal protein, large subunit |
| Alternative Names | L10, QM, DXS983 |
</div>

Overview

RPL10 (Ribosomal Protein L10) encodes a component of the large (60S) ribosomal subunit essential for protein synthesis in all cells, including [neurons](/cell-types/neurons). Originally identified as a tumor suppressor (QM protein), RPL10 has gained attention for its role in neurodegenerative diseases through connections to translation regulation, ribosomal dysfunction, and protein homeostasis failures that are central to [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) [1](https://pubmed.ncbi.nlm.nih.gov/25776775/).

Mutations in RPL10 and related ribosomal proteins cause X-linked intellectual disability and have been implicated in autism spectrum disorders, highlighting the importance of proper ribosomal function in neurodevelopment [2](https://pubmed.ncbi.nlm.nih.gov/25494167/). This page provides a comprehensive overview of RPL10's molecular function, disease associations, and therapeutic implications.

Molecular Function

Ribosomal Structure

RPL10 is a component of the 60S large ribosomal subunit, one of two subunits that comprise the ribosome [3](https://pubmed.ncbi.nlm.nih.gov/12477931/):

Ribosome Structure:
┌─────────────────┐
│ 40S Small │ ← 18S rRNA + 33 proteins
│ Subunit │
└────────┬────────┘
↓ mRNA
┌────────┬────────┐
│ 60S Large │ ← 28S rRNA + 5.8S rRNA + 5S rRNA + ~47 proteins
│ Subunit │ (including RPL10)
└─────────────────┘
↓
Polypeptide chain

RPL10 is located at the subunit interface and plays critical roles in:

• Ribosome assembly: Proper folding and assembly of the 60S subunit
• Translation elongation: Stabilization of tRNA binding
• Ribosome quality control: Detection of stalled or defective ribosomes
• Polysome formation: Assembly of translation-active polysomes

Protein-Protein Interactions

RPL10 interacts with several key proteins [4](https://pubmed.ncbi.nlm.nih.gov/22973039/):

| Partner | Interaction | Function |
|---------|-------------|----------|
| RPL5 | Direct binding | Ribosome assembly |
| RPL11 | Direct binding | Ribosome assembly |
| MDM2 | Via RPL5/RPL11 | p53 regulation |
| c-MYC | Transcriptional | Translation regulation |
| eIF6 | Antagonistic | Translation initiation |

Role in Translation

The ribosome is the molecular machine that translates mRNA into protein. RPL10 contributes to [5](https://pubmed.ncbi.nlm.nih.gov/26416545/):

Role in Neurodegeneration

Translation Dysregulation

RPL10 and ribosomal dysfunction contribute to neurodegeneration through translation dysregulation [6](https://pubmed.ncbi.nlm.nih.gov/26525479/):

Ribosomal dysfunction
↓
Global translation decline
↓
Proteostasis failure
↓
Stress granule formation
↓
Neuronal vulnerability
↓
Cell death

Key mechanisms include:

Proteostasis Failure

The [protein homeostasis (proteostasis) pathway](/mechanisms/protein-clearance) is critical for neuronal health, and RPL10 dysfunction contributes to its failure [7](https://pubmed.ncbi.nlm.nih.gov/25649656/):

Protein synthesis defects:

• Decreased synthesis of synaptic proteins
• Impaired activity-dependent translation
• Failure to replace damaged proteins

• Defective ribosomal products (DiP)
• Aggregated protein inclusions
• Impaired autophagy

• Increased amyloid-beta synthesis
• Enhanced tau phosphorylation
• Alpha-synuclein overexpression

Stress Granules

Ribosomal dysfunction triggers stress granule formation, which is implicated in [neurodegeneration](/mechanisms/stress-granules-in-neurodegeneration) [8](https://pubmed.ncbi.nlm.nih.gov/25937391/):

• Stress granules are RNA-protein aggregates that form when translation is inhibited
• Persistent stress granules become pathological inclusions
• TDP-43 and FUS co-localize with stress granules
• Stress granule dynamics are altered in ALS, FTD, and AD

Synaptic Dysfunction

Neurons are particularly vulnerable to ribosomal dysfunction due to their reliance on local translation for synaptic function [9](https://pubmed.ncbi.nlm.nih.gov/26481473/):

• Synaptic plasticity requires rapid protein synthesis
• RPL10 dysfunction impairs synaptic protein synthesis
• Memory consolidation is translation-dependent
• Synaptic scaling requires new protein synthesis

Apoptosis

Ribosomal stress triggers apoptotic pathways through several mechanisms [10](https://pubmed.ncbi.nlm.nih.gov/25009231/):

Disease Associations

Alzheimer's Disease

RPL10 and ribosomal dysfunction play significant roles in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis [11](https://pubmed.ncbi.nlm.nih.gov/26365177/):

Evidence:

• Ribosomal RNA levels decreased in AD brain
• Translation efficiency impaired in AD neurons
• RPL10 expression altered in hippocampus
• Synaptic ribosomes particularly vulnerable

• Amyloid-beta impairs translation machinery
• Tau pathology disrupts ribosomal function
• Energy deficits reduce translation capacity
• ER stress inhibits translation

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), ribosomal dysfunction contributes to dopaminergic neuron vulnerability [12](https://pubmed.ncbi.nlm.nih.gov/27235763/):

• Alpha-synuclein aggregates interfere with translation
• Mitochondrial dysfunction affects ribosomal maintenance
• RPL10 variants may modify PD risk
• Protein synthesis capacity declines with age

Amyotrophic Lateral Sclerosis

RPL10 variants have been identified in [ALS](/diseases/amyotrophic-lateral-sclerosis) patients [13](https://pubmed.ncbi.nlm.nih.gov/26037643/):

• Ribosomal protein mutations in familial ALS
• Translation defects in motor neurons
• Stress granule pathology
• C9orf72 repeat stress affects translation

Intellectual Disability

RPL10 mutations cause X-linked intellectual disability (XLID) through impaired ribosomal function [14](https://pubmed.ncbi.nlm.nih.gov/25494167/):

• RPL10 variants identified in families with ID
• Impaired neurite outgrowth
• Synaptic dysfunction
• Behavioral phenotypes

Autism Spectrum Disorder

RPL10 is implicated in [autism spectrum disorder](/diseases/autism-spectrum-disorder) through translation regulation [15](https://pubmed.ncbi.nlm.nih.gov/26057671/):

• RPL10 mutations in ASD patients
• Altered synaptic translation
• Social behavior deficits in models
• Interaction with fragile X pathway

Expression Pattern

RPL10 is ubiquitously expressed with high levels in metabolically active cells:

| Tissue | Expression Level |
|--------|-----------------|
| Brain | High (neurons) |
| Liver | High |
| Kidney | High |
| Heart | Moderate-high |
| Skeletal muscle | Moderate |
| Lung | Moderate |

In the brain, RPL10 is expressed in:

• [Cerebral cortex](/brain-regions/cortex) (all layers)
• [Hippocampus](/brain-regions/hippocampus) (CA1-3, dentate gyrus)
• [Cerebellum](/brain-regions/cerebellum) (Purkinje cells)
• [Substantia nigra](/brain-regions/substantia-nigra) (dopaminergic neurons)
• Spinal cord (motor neurons)

Therapeutic Implications

Translation Modulators

Targeting translation pathways may benefit neurodegenerative diseases [17](https://pubmed.ncbi.nlm.nih.gov/26678794/):

• eIF2α modulators: ISRIB, integrated stress response inhibitors
• mTOR inhibitors: Rapamycin, rapamycin analogs
• Translation activators: eIF4E targeting compounds
• Ribosome stabilizers: Small molecules to enhance ribosomal function

Gene Therapy

RPL10 represents a potential target for gene therapy in ribosomal disorders:

• Wild-type RPL10 delivery
• Splice-switching oligonucleotides
• CRISPR-based correction
• miRNA-mediated regulation

Small Molecules

Pharmacological approaches to enhance ribosomal function:

• Ribosome assembly enhancers
• Translation elongation promoters
• Antioxidants to reduce ribosomal stress
• Mitochondrial function enhancers

Genetics

Variants and Pathogenicity

| Variant Type | Examples | Associated Phenotype |
|--------------|----------|---------------------|
| Missense | p.Arg98Cys, p.Pro94Leu | Intellectual disability |
| Nonsense | p.Tyr226Ter | Intellectual disability |
| Splice site | c.505-1G>A | Intellectual disability |
| Frameshift | c.350delC | Intellectual disability |

Inheritance

RPL10 is located on the X chromosome (Xq28), and pathogenic variants follow X-linked inheritance [18](https://pubmed.ncbi.nlm.nih.gov/23168681/):

• Males (XY) are affected (hemizygous)
• Females (XX) are typically carriers
• Female carriers may have mild symptoms (skewed X-inactivation)
• 50% chance of carrier status in daughters

Population Genetics

• RPL10 is highly conserved across species
• Minor allele frequencies for pathogenic variants are very low
• Founder mutations identified in certain populations

Interaction Network

Ribosomal Proteins

RPL10 interacts with other ribosomal proteins in the 60S subunit [19](https://pubmed.ncbi.nlm.nih.gov/21358641/):

• RPL5 (ribosomal assembly)
• RPL11 (ribosomal assembly)
• RPL23 (ribosomal stability)
• RPL39 (ribosomal function)

Signaling Pathways

RPL10 participates in several signaling pathways:

• p53 pathway (via MDM2)
• mTOR signaling (translation regulation)
• Integrated stress response (eIF2α phosphorylation)
• c-MYC transcriptional program

Disease Pathways

• [Protein synthesis pathway](/mechanisms/protein-synthesis)
• [Proteostasis network](/mechanisms/protein-clearance)
• [Stress response pathways](/mechanisms/stress-granules-in-neurodegeneration)
• [Apoptosis pathway](/mechanisms/apoptosis-neurodegeneration)

Animal Models

Mouse Models

Rpl10 knockout mice are embryonic lethal, highlighting its essential function:

• Rpl10 deletion causes early embryonic death
• Heterozygous mice show subtle phenotypes
• Conditional knockouts in brain show translation defects

Zebra Fish Models

Zebra fish provide accessible models for studying RPL10:

• Morpholino knockdown causes developmental defects
• Behavioral deficits in models
• Rescue experiments demonstrate function

Invertebrate Models

Drosophila and C. elegans models reveal evolutionarily conserved functions:

• Homologs: RpL10 in Drosophila, rpl-10 in C. elegans
• Loss-of-function causes neurological phenotypes
• Useful for genetic modifier screens

Key Research Findings

Biochemical Mechanisms

Ribosome Assembly Pathway

RPL10 assembly follows a coordinated pathway [20](https://pubmed.ncbi.nlm.nih.gov/24307226/):

Pre-rRNA transcription (nucleolus)
↓
Early assembly (40S precursor)
↓
Late assembly (60S precursor)
↓ RPL10 incorporation
Mature 60S subunit
↓
80S ribosome formation

Translational Regulation

RPL10 contributes to several translation regulation mechanisms:

Quality Control

Ribosomal quality control pathways monitor RPL10 function:

• No-go decay: Stalled ribosome clearance
• Non-stop decay: mRNA lacking stop codon
• Ribosome-associated quality control: Co-translational monitoring
• RQC: Listerin-dependent decay of incomplete proteins

Clinical Significance

Diagnostic Testing

Genetic testing for RPL10 variants:

• Targeted sequencing
• Whole exome sequencing
• X-chromosome panel

• Translation efficiency in lymphoblasts
• Ribosome assembly analysis
• p53 activation markers

Clinical Management

For RPL10-related disorders:

• Supportive care for intellectual disability
• Behavioral interventions
• Physical therapy
• Speech therapy

• Translation-targeted therapeutics
• Symptomatic treatment
• Disease-modifying strategies in development

Research Directions

Current Research Focus

Unresolved Questions

• What determines neuronal specificity of ribosomal dysfunction?
• Can ribosomal function be restored in adult neurons?
• What is the relationship between RPL10 and other ribosomal proteins in disease?
• How does aging interact with ribosomal dysfunction?
• What are the best targets for translation-based therapy?

Emerging Technologies

• Ribosome profiling: Genome-wide analysis of translation
• Single-cell ribosome sequencing: Cellular resolution of translation
• CRISPR screening: Genetic modifiers of ribosomal stress
• Organoid models: Human brain models for RPL10 studies

Biochemical Mechanisms in Detail

RPL10 in Ribosome Biogenesis

Ribosome biogenesis is a complex process that occurs primarily in the nucleolus [21](https://pubmed.ncbi.nlm.nih.gov/25834167/):

Stage 1: Pre-rRNA transcription

• RNA Pol I transcribes 45S pre-rRNA
• Processing begins co-transcriptionally
• Early spacing elements required

• 45S cleavage generates 18S (40S) and 28S/5.8S/5S (60S) precursors
• Small subunit processome assembly
• U3 snoRNA interactions

• 60S subunit maturation
• RPL10 incorporation (late step)
• Nuclear export

• Final processing steps
• Quality control checks
• Translation competence

• Pre-60S accumulation
• Nuclear export defects
• Ribosome assembly stress

RPL10 in Translation Quality Control

The ribosome acts as a quality control checkpoint for protein synthesis [22](https://pubmed.ncbi.nlm.nih.gov/25834168/):

Stalled ribosome rescue:

Non-stop decay:

No-go decay:

RPL10 dysfunction impairs these quality control mechanisms, leading to:

• Defective translation products
• Ribosome collision stress
• Proteostatic overload

RPL10 and the Unfolded Protein Response

Misfolded proteins trigger the [unfolded protein response (UPR)](https://pubmed.ncbi.nlm.nih.gov/25966720/) [23](https://pubmed.ncbi.nlm.nih.gov/25966720/):

ER UPR:

• IRE1 activation
• XBP1 splicing
• ATF6 activation

• eIF2α phosphorylation
• ATF4 translation
• CHOP expression

• Accumulation of misfolded proteins
• Ribosome-associated stress
• Proteasome overload

RPL10 in Mitochondrial Function

Cross-talk between ribosomes and mitochondria involves [24](https://pubmed.ncbi.nlm.nih.gov/26041676/):

Mitochondrial translation:

• Mitochondrial ribosomes (mitoribosomes)
• Distinct from cytoplasmic ribosomes
• Essential for ETC complex assembly

• ATP required for translation
• NADH/ATP ratio affects translation
• Mitochondrial dysfunction impairs translation

• Damaged mitochondria cleared by mitophagy
• Translation stress triggers mitophagy
• Quality control at organelle level

• Cellular energy status
• Calcium homeostasis
• Apoptotic signaling

Comparative Biology

Evolutionary Conservation

RPL10 is highly conserved across eukaryotes [25](https://pubmed.ncbi.nlm.nih.gov/25776776/):

| Species | RPL10 Homolog | Identity |
|---------|--------------|----------|
| Human | RPL10 | 100% |
| Mouse | Rpl10 | 99% |
| Zebra fish | rpl10 | 87% |
| Drosophila | RpL10 | 71% |
| C. elegans | rpl-10 | 62% |
| Yeast | Rpl10p | 55% |

This conservation reflects essential function in ribosome biology.

Species-Specific Phenotypes

• Mice: Embryonic lethal knockout, heterozygotes viable
• Zebra fish: Developmental defects, behavioral changes
• Drosophila: Flight defects, neurodegeneration
• C. elegans: Movement defects, reduced lifespan
• Yeast: Growth defects, translation impairment

Model System Comparison

| Model | Advantages | Limitations |
|-------|------------|-------------|
| Yeast | Fast, genetic tractable | Evolutionary distance |
| C. elegans | Neurons, behavior | Limited genetics |
| Drosophila | Genetics, neurons | Limited tissue types |
| Zebra fish | Development, imaging | Brain complexity |
| Mouse | Mammalian physiology | Cost, time |

Epidemiology

Disease Prevalence

RPL10-related intellectual disability:

• Rare: <1:100,000
• Majority of cases are sporadic
• Family history sometimes positive

• Not directly causative
• May be modifier gene
• Risk contribution unclear

Geographic Distribution

• Cases reported worldwide
• Founder mutations in specific populations
• Most variants are private

Age Distribution

• Intellectual disability: Diagnosed in childhood
• Neurodegeneration: Adult onset
• Modifier effects: Variable age of onset

Economic Impact

Healthcare Costs

• Diagnostic testing: $1,000-5,000 per patient
• Management: $10,000-50,000 annually
• Research funding: $10M+ annually

Societal Impact

• Caregiver burden significant
• Educational interventions costly
• Lost productivity

Future Directions

Therapeutic Development

Biomarker Development

• Translation efficiency in blood cells
• Ribosome assembly markers
• Stress granule quantification
• Polysome profiling

Prevention Strategies

• Preimplantation genetic testing
• Prenatal diagnosis for carriers
• Newborn screening for at-risk populations

See Also

• [Ribosomal Proteins in Neurodegeneration](/mechanisms/protein-synthesis)
• [Translation Dysfunction](/mechanisms/translation-defects)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Intellectual Disability](/diseases/intellectual-disability)
• [Genes](/genes/)
• [Ribosomal Protein Genes](/genes/ribosomal-proteins-family)
• [Proteostasis Network](/mechanisms/protein-clearance)
• [Stress Granules](/mechanisms/stress-granules-in-neurodegeneration)

References